(MedPage Today) — A second Duchenne muscular dystrophy patient died after being treated with the gene therapy delandistrogene moxeparvovec (Elevidys), Sarepta Therapeutics said Sunday.
Like the first case reported, this patient developed acute…
Source link : https://www.medpagetoday.com/neurology/generalneurology/116100
Author :
Publish date : 2025-06-16 20:45:00
Copyright for syndicated content belongs to the linked Source.
